Skip to content

LivaNova LIVN Neuromodulation — Total Assets

Other segment segments

Cardiopulmonary
$1.05B+11.3%

Similar metrics at other companies

Jefferies Financial Group logo
JEFAsset Management — Total Assets
$5.45B+2.3%
Regal Rexnord logo
RRXAutomation & Motion Control — Total Assets
$4.55B-3.5%
Equitable Holdings logo
EQHAsset Management — Total Assets
$10.32B-4.8%
Abbott logo
ABTNutritional Products — Total Assets
$4.9B+5.8%
American Express logo
AXPGMNS — Total Assets
$19.35B+7.0%
Thor Industries logo
THONorth American Motorized — TOTAL ASSETS:
$1.13B+16.3%

Other financials

Income statement

See full
Revenue$362.3M+14.3%
Gross profit$243.7M+12.7%
Operating income$41.5M-14.7%
Net income$22.3M+107%
EPS (diluted)$0.40+107%

Balance sheet

See full
Cash & equivalents$539.7M-26.9%
Total debt$340.9M-49.7%
Total equity$1.2B+17.1%
Total assets$2.5B-1.7%

Cash flow

See full
Operating cash flow$15.2M-36.5%
CapEx$14.3M+32.4%
Free cash flow$926.0K-93.0%

Valuation

See full
Market cap$4.31B+62.8%
Enterprise value$4.11B+58.0%
P/S+0.9×

Profitability

See full
Gross margin67.5%-0.5pp
Operating margin13.4%+0.8pp
Net margin-16.1%-18.0pp
FCF margin11.2%-0.2pp

Returns & leverage

See full
Return on equity-17.6%-19.5pp
Debt / equity0.3×-0.4×
Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's neuromodulation — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LivaNova's neuromodulation — total assets?
LivaNova (LIVN) reported neuromodulation — total assets of $650.1M in Q1 2026.
How has LivaNova's neuromodulation — total assets changed year-over-year?
LivaNova's neuromodulation — total assets increased by 1.3% year-over-year, from $641.88M to $650.1M.
What is the long-term trend for LivaNova's neuromodulation — total assets?
Over 4 years (2021 to 2025), LivaNova's neuromodulation — total assets has grown at a -0.4% compound annual growth rate (CAGR), from $2.6B to $2.56B.
What does neuromodulation — total assets mean?
The total value of resources controlled by the Neuromodulation segment, including inventory, property, plant, equipment, and intangible assets. This metric provides insight into the capital intensity and asset base supporting the segment's operations.